nodes	percent_of_prediction	percent_of_DWPC	metapath
Milnacipran—Eye disorder—Epirubicin—hematologic cancer	0.000151	0.000151	CcSEcCtD
Milnacipran—Hypersensitivity—Etoposide—hematologic cancer	0.000151	0.000151	CcSEcCtD
Milnacipran—Malnutrition—Methotrexate—hematologic cancer	0.000151	0.000151	CcSEcCtD
Milnacipran—Headache—Gemcitabine—hematologic cancer	0.000151	0.000151	CcSEcCtD
Milnacipran—Nausea—Vincristine—hematologic cancer	0.000151	0.000151	CcSEcCtD
Milnacipran—Flushing—Epirubicin—hematologic cancer	0.00015	0.00015	CcSEcCtD
Milnacipran—Cardiac disorder—Epirubicin—hematologic cancer	0.00015	0.00015	CcSEcCtD
Milnacipran—Hepatitis—Doxorubicin—hematologic cancer	0.00015	0.00015	CcSEcCtD
Milnacipran—Hypersensitivity—Prednisolone—hematologic cancer	0.000149	0.000149	CcSEcCtD
Milnacipran—Hypoaesthesia—Doxorubicin—hematologic cancer	0.000149	0.000149	CcSEcCtD
Milnacipran—Dyspepsia—Dexamethasone—hematologic cancer	0.000149	0.000149	CcSEcCtD
Milnacipran—Dyspepsia—Betamethasone—hematologic cancer	0.000149	0.000149	CcSEcCtD
Milnacipran—Urinary tract disorder—Doxorubicin—hematologic cancer	0.000148	0.000148	CcSEcCtD
Milnacipran—Urticaria—Triamcinolone—hematologic cancer	0.000148	0.000148	CcSEcCtD
Milnacipran—Oedema peripheral—Doxorubicin—hematologic cancer	0.000148	0.000148	CcSEcCtD
Milnacipran—Dysgeusia—Methotrexate—hematologic cancer	0.000148	0.000148	CcSEcCtD
Milnacipran—Asthenia—Etoposide—hematologic cancer	0.000147	0.000147	CcSEcCtD
Milnacipran—Connective tissue disorder—Doxorubicin—hematologic cancer	0.000147	0.000147	CcSEcCtD
Milnacipran—Body temperature increased—Triamcinolone—hematologic cancer	0.000147	0.000147	CcSEcCtD
Milnacipran—Angiopathy—Epirubicin—hematologic cancer	0.000147	0.000147	CcSEcCtD
Milnacipran—Urethral disorder—Doxorubicin—hematologic cancer	0.000147	0.000147	CcSEcCtD
Milnacipran—Decreased appetite—Dexamethasone—hematologic cancer	0.000147	0.000147	CcSEcCtD
Milnacipran—Decreased appetite—Betamethasone—hematologic cancer	0.000147	0.000147	CcSEcCtD
Milnacipran—Nausea—Mitoxantrone—hematologic cancer	0.000147	0.000147	CcSEcCtD
Milnacipran—Nausea—Irinotecan—hematologic cancer	0.000147	0.000147	CcSEcCtD
Milnacipran—Infection—Prednisone—hematologic cancer	0.000146	0.000146	CcSEcCtD
Milnacipran—Mediastinal disorder—Epirubicin—hematologic cancer	0.000146	0.000146	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Betamethasone—hematologic cancer	0.000146	0.000146	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Dexamethasone—hematologic cancer	0.000146	0.000146	CcSEcCtD
Milnacipran—Fatigue—Betamethasone—hematologic cancer	0.000146	0.000146	CcSEcCtD
Milnacipran—Fatigue—Dexamethasone—hematologic cancer	0.000146	0.000146	CcSEcCtD
Milnacipran—Chills—Epirubicin—hematologic cancer	0.000145	0.000145	CcSEcCtD
Milnacipran—Pruritus—Etoposide—hematologic cancer	0.000145	0.000145	CcSEcCtD
Milnacipran—Shock—Prednisone—hematologic cancer	0.000145	0.000145	CcSEcCtD
Milnacipran—Nervous system disorder—Prednisone—hematologic cancer	0.000144	0.000144	CcSEcCtD
Milnacipran—Tachycardia—Prednisone—hematologic cancer	0.000144	0.000144	CcSEcCtD
Milnacipran—Skin disorder—Prednisone—hematologic cancer	0.000143	0.000143	CcSEcCtD
Milnacipran—Nausea—Gemcitabine—hematologic cancer	0.000143	0.000143	CcSEcCtD
Milnacipran—Vomiting—Cisplatin—hematologic cancer	0.000142	0.000142	CcSEcCtD
Milnacipran—Hyperhidrosis—Prednisone—hematologic cancer	0.000142	0.000142	CcSEcCtD
Milnacipran—Vision blurred—Methotrexate—hematologic cancer	0.000142	0.000142	CcSEcCtD
Milnacipran—Mental disorder—Epirubicin—hematologic cancer	0.000142	0.000142	CcSEcCtD
Milnacipran—Erythema multiforme—Doxorubicin—hematologic cancer	0.000142	0.000142	CcSEcCtD
Milnacipran—Rash—Cisplatin—hematologic cancer	0.000141	0.000141	CcSEcCtD
Milnacipran—Dermatitis—Cisplatin—hematologic cancer	0.000141	0.000141	CcSEcCtD
Milnacipran—Malnutrition—Epirubicin—hematologic cancer	0.000141	0.000141	CcSEcCtD
Milnacipran—Diarrhoea—Etoposide—hematologic cancer	0.00014	0.00014	CcSEcCtD
Milnacipran—Anorexia—Prednisone—hematologic cancer	0.00014	0.00014	CcSEcCtD
Milnacipran—Eye disorder—Doxorubicin—hematologic cancer	0.00014	0.00014	CcSEcCtD
Milnacipran—Flushing—Doxorubicin—hematologic cancer	0.000139	0.000139	CcSEcCtD
Milnacipran—Cardiac disorder—Doxorubicin—hematologic cancer	0.000139	0.000139	CcSEcCtD
Milnacipran—Flatulence—Epirubicin—hematologic cancer	0.000139	0.000139	CcSEcCtD
Milnacipran—Tension—Epirubicin—hematologic cancer	0.000138	0.000138	CcSEcCtD
Milnacipran—Gastrointestinal pain—Dexamethasone—hematologic cancer	0.000138	0.000138	CcSEcCtD
Milnacipran—Gastrointestinal pain—Betamethasone—hematologic cancer	0.000138	0.000138	CcSEcCtD
Milnacipran—Dysgeusia—Epirubicin—hematologic cancer	0.000138	0.000138	CcSEcCtD
Milnacipran—Hypersensitivity—Triamcinolone—hematologic cancer	0.000137	0.000137	CcSEcCtD
Milnacipran—Angiopathy—Doxorubicin—hematologic cancer	0.000136	0.000136	CcSEcCtD
Milnacipran—Dizziness—Etoposide—hematologic cancer	0.000136	0.000136	CcSEcCtD
Milnacipran—Mediastinal disorder—Doxorubicin—hematologic cancer	0.000135	0.000135	CcSEcCtD
Milnacipran—Leukopenia—Methotrexate—hematologic cancer	0.000135	0.000135	CcSEcCtD
Milnacipran—Chills—Doxorubicin—hematologic cancer	0.000134	0.000134	CcSEcCtD
Milnacipran—Urticaria—Betamethasone—hematologic cancer	0.000134	0.000134	CcSEcCtD
Milnacipran—Urticaria—Dexamethasone—hematologic cancer	0.000134	0.000134	CcSEcCtD
Milnacipran—Dizziness—Prednisolone—hematologic cancer	0.000134	0.000134	CcSEcCtD
Milnacipran—Asthenia—Triamcinolone—hematologic cancer	0.000134	0.000134	CcSEcCtD
Milnacipran—Body temperature increased—Betamethasone—hematologic cancer	0.000134	0.000134	CcSEcCtD
Milnacipran—Body temperature increased—Dexamethasone—hematologic cancer	0.000134	0.000134	CcSEcCtD
Milnacipran—Abdominal pain—Dexamethasone—hematologic cancer	0.000134	0.000134	CcSEcCtD
Milnacipran—Abdominal pain—Betamethasone—hematologic cancer	0.000134	0.000134	CcSEcCtD
Milnacipran—Nausea—Cisplatin—hematologic cancer	0.000133	0.000133	CcSEcCtD
Milnacipran—Insomnia—Prednisone—hematologic cancer	0.000133	0.000133	CcSEcCtD
Milnacipran—Vision blurred—Epirubicin—hematologic cancer	0.000133	0.000133	CcSEcCtD
Milnacipran—Paraesthesia—Prednisone—hematologic cancer	0.000132	0.000132	CcSEcCtD
Milnacipran—Pruritus—Triamcinolone—hematologic cancer	0.000132	0.000132	CcSEcCtD
Milnacipran—Mental disorder—Doxorubicin—hematologic cancer	0.000131	0.000131	CcSEcCtD
Milnacipran—Convulsion—Methotrexate—hematologic cancer	0.000131	0.000131	CcSEcCtD
Milnacipran—Vomiting—Etoposide—hematologic cancer	0.000131	0.000131	CcSEcCtD
Milnacipran—Malnutrition—Doxorubicin—hematologic cancer	0.00013	0.00013	CcSEcCtD
Milnacipran—Agitation—Epirubicin—hematologic cancer	0.00013	0.00013	CcSEcCtD
Milnacipran—Dyspepsia—Prednisone—hematologic cancer	0.00013	0.00013	CcSEcCtD
Milnacipran—Rash—Etoposide—hematologic cancer	0.000129	0.000129	CcSEcCtD
Milnacipran—Dermatitis—Etoposide—hematologic cancer	0.000129	0.000129	CcSEcCtD
Milnacipran—Headache—Etoposide—hematologic cancer	0.000129	0.000129	CcSEcCtD
Milnacipran—Flatulence—Doxorubicin—hematologic cancer	0.000129	0.000129	CcSEcCtD
Milnacipran—Chest pain—Methotrexate—hematologic cancer	0.000128	0.000128	CcSEcCtD
Milnacipran—Tension—Doxorubicin—hematologic cancer	0.000128	0.000128	CcSEcCtD
Milnacipran—Decreased appetite—Prednisone—hematologic cancer	0.000128	0.000128	CcSEcCtD
Milnacipran—Dysgeusia—Doxorubicin—hematologic cancer	0.000128	0.000128	CcSEcCtD
Milnacipran—Rash—Prednisolone—hematologic cancer	0.000128	0.000128	CcSEcCtD
Milnacipran—Dermatitis—Prednisolone—hematologic cancer	0.000128	0.000128	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—hematologic cancer	0.000127	0.000127	CcSEcCtD
Milnacipran—Fatigue—Prednisone—hematologic cancer	0.000127	0.000127	CcSEcCtD
Milnacipran—Headache—Prednisolone—hematologic cancer	0.000127	0.000127	CcSEcCtD
Milnacipran—Syncope—Epirubicin—hematologic cancer	0.000126	0.000126	CcSEcCtD
Milnacipran—Leukopenia—Epirubicin—hematologic cancer	0.000126	0.000126	CcSEcCtD
Milnacipran—Constipation—Prednisone—hematologic cancer	0.000126	0.000126	CcSEcCtD
Milnacipran—Palpitations—Epirubicin—hematologic cancer	0.000125	0.000125	CcSEcCtD
Milnacipran—Loss of consciousness—Epirubicin—hematologic cancer	0.000124	0.000124	CcSEcCtD
Milnacipran—Dizziness—Triamcinolone—hematologic cancer	0.000123	0.000123	CcSEcCtD
Milnacipran—Vision blurred—Doxorubicin—hematologic cancer	0.000123	0.000123	CcSEcCtD
Milnacipran—Convulsion—Epirubicin—hematologic cancer	0.000122	0.000122	CcSEcCtD
Milnacipran—Infection—Methotrexate—hematologic cancer	0.000122	0.000122	CcSEcCtD
Milnacipran—Nausea—Etoposide—hematologic cancer	0.000122	0.000122	CcSEcCtD
Milnacipran—Hypertension—Epirubicin—hematologic cancer	0.000122	0.000122	CcSEcCtD
Milnacipran—Asthenia—Betamethasone—hematologic cancer	0.000121	0.000121	CcSEcCtD
Milnacipran—Asthenia—Dexamethasone—hematologic cancer	0.000121	0.000121	CcSEcCtD
Milnacipran—Nervous system disorder—Methotrexate—hematologic cancer	0.000121	0.000121	CcSEcCtD
Milnacipran—Thrombocytopenia—Methotrexate—hematologic cancer	0.00012	0.00012	CcSEcCtD
Milnacipran—Gastrointestinal pain—Prednisone—hematologic cancer	0.00012	0.00012	CcSEcCtD
Milnacipran—Nausea—Prednisolone—hematologic cancer	0.00012	0.00012	CcSEcCtD
Milnacipran—Chest pain—Epirubicin—hematologic cancer	0.00012	0.00012	CcSEcCtD
Milnacipran—Agitation—Doxorubicin—hematologic cancer	0.00012	0.00012	CcSEcCtD
Milnacipran—Anxiety—Epirubicin—hematologic cancer	0.00012	0.00012	CcSEcCtD
Milnacipran—Pruritus—Betamethasone—hematologic cancer	0.00012	0.00012	CcSEcCtD
Milnacipran—Pruritus—Dexamethasone—hematologic cancer	0.00012	0.00012	CcSEcCtD
Milnacipran—Skin disorder—Methotrexate—hematologic cancer	0.000119	0.000119	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Epirubicin—hematologic cancer	0.000119	0.000119	CcSEcCtD
Milnacipran—Hyperhidrosis—Methotrexate—hematologic cancer	0.000119	0.000119	CcSEcCtD
Milnacipran—Vomiting—Triamcinolone—hematologic cancer	0.000118	0.000118	CcSEcCtD
Milnacipran—Rash—Triamcinolone—hematologic cancer	0.000117	0.000117	CcSEcCtD
Milnacipran—Dry mouth—Epirubicin—hematologic cancer	0.000117	0.000117	CcSEcCtD
Milnacipran—Dermatitis—Triamcinolone—hematologic cancer	0.000117	0.000117	CcSEcCtD
Milnacipran—Anorexia—Methotrexate—hematologic cancer	0.000117	0.000117	CcSEcCtD
Milnacipran—Syncope—Doxorubicin—hematologic cancer	0.000117	0.000117	CcSEcCtD
Milnacipran—Urticaria—Prednisone—hematologic cancer	0.000117	0.000117	CcSEcCtD
Milnacipran—Leukopenia—Doxorubicin—hematologic cancer	0.000117	0.000117	CcSEcCtD
Milnacipran—Headache—Triamcinolone—hematologic cancer	0.000117	0.000117	CcSEcCtD
Milnacipran—Abdominal pain—Prednisone—hematologic cancer	0.000116	0.000116	CcSEcCtD
Milnacipran—Body temperature increased—Prednisone—hematologic cancer	0.000116	0.000116	CcSEcCtD
Milnacipran—Diarrhoea—Betamethasone—hematologic cancer	0.000116	0.000116	CcSEcCtD
Milnacipran—Diarrhoea—Dexamethasone—hematologic cancer	0.000116	0.000116	CcSEcCtD
Milnacipran—Palpitations—Doxorubicin—hematologic cancer	0.000115	0.000115	CcSEcCtD
Milnacipran—Hypotension—Methotrexate—hematologic cancer	0.000115	0.000115	CcSEcCtD
Milnacipran—Loss of consciousness—Doxorubicin—hematologic cancer	0.000115	0.000115	CcSEcCtD
Milnacipran—Infection—Epirubicin—hematologic cancer	0.000114	0.000114	CcSEcCtD
Milnacipran—Shock—Epirubicin—hematologic cancer	0.000113	0.000113	CcSEcCtD
Milnacipran—Convulsion—Doxorubicin—hematologic cancer	0.000113	0.000113	CcSEcCtD
Milnacipran—Nervous system disorder—Epirubicin—hematologic cancer	0.000113	0.000113	CcSEcCtD
Milnacipran—Thrombocytopenia—Epirubicin—hematologic cancer	0.000113	0.000113	CcSEcCtD
Milnacipran—Hypertension—Doxorubicin—hematologic cancer	0.000113	0.000113	CcSEcCtD
Milnacipran—Tachycardia—Epirubicin—hematologic cancer	0.000112	0.000112	CcSEcCtD
Milnacipran—Skin disorder—Epirubicin—hematologic cancer	0.000112	0.000112	CcSEcCtD
Milnacipran—Dizziness—Dexamethasone—hematologic cancer	0.000112	0.000112	CcSEcCtD
Milnacipran—Dizziness—Betamethasone—hematologic cancer	0.000112	0.000112	CcSEcCtD
Milnacipran—Hyperhidrosis—Epirubicin—hematologic cancer	0.000111	0.000111	CcSEcCtD
Milnacipran—Insomnia—Methotrexate—hematologic cancer	0.000111	0.000111	CcSEcCtD
Milnacipran—Chest pain—Doxorubicin—hematologic cancer	0.000111	0.000111	CcSEcCtD
Milnacipran—Anxiety—Doxorubicin—hematologic cancer	0.000111	0.000111	CcSEcCtD
Milnacipran—Nausea—Triamcinolone—hematologic cancer	0.000111	0.000111	CcSEcCtD
Milnacipran—Paraesthesia—Methotrexate—hematologic cancer	0.00011	0.00011	CcSEcCtD
Milnacipran—Unspecified disorder of skin and subcutaneous tissue—Doxorubicin—hematologic cancer	0.00011	0.00011	CcSEcCtD
Milnacipran—Anorexia—Epirubicin—hematologic cancer	0.00011	0.00011	CcSEcCtD
Milnacipran—Dyspnoea—Methotrexate—hematologic cancer	0.00011	0.00011	CcSEcCtD
Milnacipran—Somnolence—Methotrexate—hematologic cancer	0.000109	0.000109	CcSEcCtD
Milnacipran—Dry mouth—Doxorubicin—hematologic cancer	0.000109	0.000109	CcSEcCtD
Milnacipran—Hypersensitivity—Prednisone—hematologic cancer	0.000108	0.000108	CcSEcCtD
Milnacipran—Dyspepsia—Methotrexate—hematologic cancer	0.000108	0.000108	CcSEcCtD
Milnacipran—Hypotension—Epirubicin—hematologic cancer	0.000108	0.000108	CcSEcCtD
Milnacipran—Vomiting—Dexamethasone—hematologic cancer	0.000107	0.000107	CcSEcCtD
Milnacipran—Vomiting—Betamethasone—hematologic cancer	0.000107	0.000107	CcSEcCtD
Milnacipran—Decreased appetite—Methotrexate—hematologic cancer	0.000107	0.000107	CcSEcCtD
Milnacipran—Rash—Dexamethasone—hematologic cancer	0.000107	0.000107	CcSEcCtD
Milnacipran—Rash—Betamethasone—hematologic cancer	0.000107	0.000107	CcSEcCtD
Milnacipran—Dermatitis—Betamethasone—hematologic cancer	0.000106	0.000106	CcSEcCtD
Milnacipran—Dermatitis—Dexamethasone—hematologic cancer	0.000106	0.000106	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Methotrexate—hematologic cancer	0.000106	0.000106	CcSEcCtD
Milnacipran—Fatigue—Methotrexate—hematologic cancer	0.000106	0.000106	CcSEcCtD
Milnacipran—Headache—Dexamethasone—hematologic cancer	0.000106	0.000106	CcSEcCtD
Milnacipran—Headache—Betamethasone—hematologic cancer	0.000106	0.000106	CcSEcCtD
Milnacipran—Infection—Doxorubicin—hematologic cancer	0.000106	0.000106	CcSEcCtD
Milnacipran—Asthenia—Prednisone—hematologic cancer	0.000106	0.000106	CcSEcCtD
Milnacipran—Shock—Doxorubicin—hematologic cancer	0.000105	0.000105	CcSEcCtD
Milnacipran—Nervous system disorder—Doxorubicin—hematologic cancer	0.000104	0.000104	CcSEcCtD
Milnacipran—Thrombocytopenia—Doxorubicin—hematologic cancer	0.000104	0.000104	CcSEcCtD
Milnacipran—Pruritus—Prednisone—hematologic cancer	0.000104	0.000104	CcSEcCtD
Milnacipran—Insomnia—Epirubicin—hematologic cancer	0.000104	0.000104	CcSEcCtD
Milnacipran—Tachycardia—Doxorubicin—hematologic cancer	0.000104	0.000104	CcSEcCtD
Milnacipran—Skin disorder—Doxorubicin—hematologic cancer	0.000103	0.000103	CcSEcCtD
Milnacipran—Paraesthesia—Epirubicin—hematologic cancer	0.000103	0.000103	CcSEcCtD
Milnacipran—Hyperhidrosis—Doxorubicin—hematologic cancer	0.000103	0.000103	CcSEcCtD
Milnacipran—Dyspnoea—Epirubicin—hematologic cancer	0.000103	0.000103	CcSEcCtD
Milnacipran—Somnolence—Epirubicin—hematologic cancer	0.000102	0.000102	CcSEcCtD
Milnacipran—Anorexia—Doxorubicin—hematologic cancer	0.000102	0.000102	CcSEcCtD
Milnacipran—Dyspepsia—Epirubicin—hematologic cancer	0.000101	0.000101	CcSEcCtD
Milnacipran—Diarrhoea—Prednisone—hematologic cancer	0.000101	0.000101	CcSEcCtD
Milnacipran—Gastrointestinal pain—Methotrexate—hematologic cancer	0.000101	0.000101	CcSEcCtD
Milnacipran—Nausea—Dexamethasone—hematologic cancer	0.0001	0.0001	CcSEcCtD
Milnacipran—Nausea—Betamethasone—hematologic cancer	0.0001	0.0001	CcSEcCtD
Milnacipran—Decreased appetite—Epirubicin—hematologic cancer	0.0001	0.0001	CcSEcCtD
Milnacipran—Hypotension—Doxorubicin—hematologic cancer	9.95e-05	9.95e-05	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Epirubicin—hematologic cancer	9.94e-05	9.94e-05	CcSEcCtD
Milnacipran—Fatigue—Epirubicin—hematologic cancer	9.92e-05	9.92e-05	CcSEcCtD
Milnacipran—Constipation—Epirubicin—hematologic cancer	9.84e-05	9.84e-05	CcSEcCtD
Milnacipran—Urticaria—Methotrexate—hematologic cancer	9.77e-05	9.77e-05	CcSEcCtD
Milnacipran—Dizziness—Prednisone—hematologic cancer	9.73e-05	9.73e-05	CcSEcCtD
Milnacipran—Abdominal pain—Methotrexate—hematologic cancer	9.72e-05	9.72e-05	CcSEcCtD
Milnacipran—Body temperature increased—Methotrexate—hematologic cancer	9.72e-05	9.72e-05	CcSEcCtD
Milnacipran—Insomnia—Doxorubicin—hematologic cancer	9.63e-05	9.63e-05	CcSEcCtD
Milnacipran—Paraesthesia—Doxorubicin—hematologic cancer	9.56e-05	9.56e-05	CcSEcCtD
Milnacipran—Dyspnoea—Doxorubicin—hematologic cancer	9.49e-05	9.49e-05	CcSEcCtD
Milnacipran—Somnolence—Doxorubicin—hematologic cancer	9.47e-05	9.47e-05	CcSEcCtD
Milnacipran—Gastrointestinal pain—Epirubicin—hematologic cancer	9.41e-05	9.41e-05	CcSEcCtD
Milnacipran—Dyspepsia—Doxorubicin—hematologic cancer	9.37e-05	9.37e-05	CcSEcCtD
Milnacipran—Vomiting—Prednisone—hematologic cancer	9.36e-05	9.36e-05	CcSEcCtD
Milnacipran—Rash—Prednisone—hematologic cancer	9.28e-05	9.28e-05	CcSEcCtD
Milnacipran—Dermatitis—Prednisone—hematologic cancer	9.27e-05	9.27e-05	CcSEcCtD
Milnacipran—Decreased appetite—Doxorubicin—hematologic cancer	9.26e-05	9.26e-05	CcSEcCtD
Milnacipran—Headache—Prednisone—hematologic cancer	9.22e-05	9.22e-05	CcSEcCtD
Milnacipran—Gastrointestinal disorder—Doxorubicin—hematologic cancer	9.19e-05	9.19e-05	CcSEcCtD
Milnacipran—Fatigue—Doxorubicin—hematologic cancer	9.18e-05	9.18e-05	CcSEcCtD
Milnacipran—Urticaria—Epirubicin—hematologic cancer	9.14e-05	9.14e-05	CcSEcCtD
Milnacipran—Constipation—Doxorubicin—hematologic cancer	9.11e-05	9.11e-05	CcSEcCtD
Milnacipran—Abdominal pain—Epirubicin—hematologic cancer	9.1e-05	9.1e-05	CcSEcCtD
Milnacipran—Body temperature increased—Epirubicin—hematologic cancer	9.1e-05	9.1e-05	CcSEcCtD
Milnacipran—Hypersensitivity—Methotrexate—hematologic cancer	9.06e-05	9.06e-05	CcSEcCtD
Milnacipran—Asthenia—Methotrexate—hematologic cancer	8.82e-05	8.82e-05	CcSEcCtD
Milnacipran—Nausea—Prednisone—hematologic cancer	8.74e-05	8.74e-05	CcSEcCtD
Milnacipran—Gastrointestinal pain—Doxorubicin—hematologic cancer	8.71e-05	8.71e-05	CcSEcCtD
Milnacipran—Pruritus—Methotrexate—hematologic cancer	8.7e-05	8.7e-05	CcSEcCtD
Milnacipran—Hypersensitivity—Epirubicin—hematologic cancer	8.48e-05	8.48e-05	CcSEcCtD
Milnacipran—Urticaria—Doxorubicin—hematologic cancer	8.46e-05	8.46e-05	CcSEcCtD
Milnacipran—Abdominal pain—Doxorubicin—hematologic cancer	8.42e-05	8.42e-05	CcSEcCtD
Milnacipran—Body temperature increased—Doxorubicin—hematologic cancer	8.42e-05	8.42e-05	CcSEcCtD
Milnacipran—Diarrhoea—Methotrexate—hematologic cancer	8.41e-05	8.41e-05	CcSEcCtD
Milnacipran—Asthenia—Epirubicin—hematologic cancer	8.26e-05	8.26e-05	CcSEcCtD
Milnacipran—Pruritus—Epirubicin—hematologic cancer	8.14e-05	8.14e-05	CcSEcCtD
Milnacipran—Dizziness—Methotrexate—hematologic cancer	8.13e-05	8.13e-05	CcSEcCtD
Milnacipran—Diarrhoea—Epirubicin—hematologic cancer	7.87e-05	7.87e-05	CcSEcCtD
Milnacipran—Hypersensitivity—Doxorubicin—hematologic cancer	7.85e-05	7.85e-05	CcSEcCtD
Milnacipran—Vomiting—Methotrexate—hematologic cancer	7.82e-05	7.82e-05	CcSEcCtD
Milnacipran—Rash—Methotrexate—hematologic cancer	7.75e-05	7.75e-05	CcSEcCtD
Milnacipran—Dermatitis—Methotrexate—hematologic cancer	7.75e-05	7.75e-05	CcSEcCtD
Milnacipran—Headache—Methotrexate—hematologic cancer	7.7e-05	7.7e-05	CcSEcCtD
Milnacipran—Asthenia—Doxorubicin—hematologic cancer	7.64e-05	7.64e-05	CcSEcCtD
Milnacipran—Dizziness—Epirubicin—hematologic cancer	7.61e-05	7.61e-05	CcSEcCtD
Milnacipran—Pruritus—Doxorubicin—hematologic cancer	7.53e-05	7.53e-05	CcSEcCtD
Milnacipran—Vomiting—Epirubicin—hematologic cancer	7.32e-05	7.32e-05	CcSEcCtD
Milnacipran—Nausea—Methotrexate—hematologic cancer	7.31e-05	7.31e-05	CcSEcCtD
Milnacipran—Diarrhoea—Doxorubicin—hematologic cancer	7.29e-05	7.29e-05	CcSEcCtD
Milnacipran—Rash—Epirubicin—hematologic cancer	7.26e-05	7.26e-05	CcSEcCtD
Milnacipran—Dermatitis—Epirubicin—hematologic cancer	7.25e-05	7.25e-05	CcSEcCtD
Milnacipran—Headache—Epirubicin—hematologic cancer	7.21e-05	7.21e-05	CcSEcCtD
Milnacipran—Dizziness—Doxorubicin—hematologic cancer	7.04e-05	7.04e-05	CcSEcCtD
Milnacipran—Nausea—Epirubicin—hematologic cancer	6.84e-05	6.84e-05	CcSEcCtD
Milnacipran—Vomiting—Doxorubicin—hematologic cancer	6.77e-05	6.77e-05	CcSEcCtD
Milnacipran—Rash—Doxorubicin—hematologic cancer	6.71e-05	6.71e-05	CcSEcCtD
Milnacipran—Dermatitis—Doxorubicin—hematologic cancer	6.71e-05	6.71e-05	CcSEcCtD
Milnacipran—Headache—Doxorubicin—hematologic cancer	6.67e-05	6.67e-05	CcSEcCtD
Milnacipran—Nausea—Doxorubicin—hematologic cancer	6.33e-05	6.33e-05	CcSEcCtD
